Skip to main content

Table 1 Histopathological diagnosis of 716 patients with sacral malignant tumors

From: Epidemiological characteristics of 1385 primary sacral tumors in one institution in China

Primary malignant tumor No.(percentage) in malignant tumors No.(percentage) in all patients
Chordoma 316 (44.1%) 316 (22.8%)
Chondrosarcoma 74 (10.3%) 74 (5.3%)
Myeloma 53 (7.4%) 53 (3.8%)
Malignant peripheral nerve sheath tumor 47 (6.6%) 47 (3.4%)
Ewing sarcoma 47 (6.6%) 47 (3.4%)
Osteosarcoma 40 (5.6%) 40 (2.9%)
Lymphoma 35 (4.9%) 35 (2.5%)
Solitary fibrous tumor 20 (2.8%) 20 (1.4%)
Undifferentiated pleomorphic sarcoma 17 (2.4%) 17 (1.2%)
Malignant giant cell tumor 17 (2.4%) 17 (1.2%)
Malignant teratoma 11 (1.5%) 11 (0.8%)
Liposarcoma 10 (1.4%) 10 (0.7%)
Ependymoma 4 (0.6%) 4 (0.3%)
Angiosarcoma 3 (0.4%) 3 (0.2%)
Fibrosarcoma 3 (0.4%) 3 (0.2%)
Hemangioendothelima 3 (0.4%) 3 (0.2%)
Myelocytic sarcoma 3 (0.4%) 3 (0.2%)
Yolk sac tumor 3 (0.4%) 3 (0.2%)
Leiomyosarcoma 2 (0.3%) 2 (0.1%)
Alveolar soft part sarcoma 2 (0.3%) 2 (0.1%)
Leukemia 2 (0.3%) 2 (0.1%)
Epithelioid sarcoma 1 (0.1%) 1 (0.07%)
Granulocyte sarcoma 1 (0.1%) 1 (0.07%)
Myofibroblastic sarcoma 1 (0.1%) 1 (0.07%)
Synovial sarcoma 1 (0.1%) 1 (0.07%)